Newsletter | April 9, 2025

04.09.25 -- Takeda's Award-Winning Facility Teaches You About Outsourcing

INDUSTRY INSIGHTS

The 5 Key Risks Of Failing To Select The Right CDMO Partner

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.

Diagnose Absorption Risks To Improve Preclinical And Clinical Outcomes

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Choosing The Right CDMO For Your Project — Part One: Will They Deliver?

Selecting the right CDMO is crucial for the success of your pharmaceutical project. Learn how to strike the ideal balance between an organization's technical expertise, facilities, and efficiency.

FEATURED EDITORIAL

Takeda's Award-Winning Facility Teaches You About Outsourcing

A Takeda production site in Linz, Austria, received an ISPE’s 2024 Facility of The Year Award. What’s so special about that location? The explanation from Roland Fabris, Site Head, will actually help you benchmark your CDMO, and demonstrate much about facility selection applicable to your own outsourcing needs. 

Approaching Tech Transfers And Sponsored Life Sciences Research In An AI Age

Two IP attorneys examine the patentability of AI-conceived inventions and share tips for technology transfers and sponsored research in pharma/biotech.

INDUSTRY INSIGHTS CONTINUED

Technical Considerations For Selecting Softgels As An Oral Dosage Form

The unique characteristics of softgel capsules can play a pivotal role in the success of a drug. By addressing stability and shelf-life challenges, softgels have become a valuable tool for manufacturers.

Common Tablet Defects And The Importance Of Blending

Review several methods for minimizing tablet defects like picking, sticking, and capping. This presentation explores common issues and the critical role of blending in achieving quality tablets.

How High Drug Load Nanocrystalline Tablets Lower Pill Burden

Here, we showcase the development of high drug load nanocrystal-based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.

SOLUTIONS

Designed For Inhalation: Pulmonary And Nasal Delivery

Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.

Your One-Stop Solution For Drug Product Manufacturing

Explore our global network’s comprehensive drug product capabilities and contact us today to streamline your outsourcing solutions with no added costs.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: